In the last decade, the use of multipotential progenitor cells has received a great deal of attention to promote tendon healing. It has become technically feasible to harvest tissue cells, to expand cell population in culture, and therefore to inject them into injured tendon (1). Stem cells (SCs), under the influence of endogenous and exogenous factors, can subsequently differentiate into tissue – specific cells, favouring tendon repair.
Bone marrow – derived SCs have been used in several studies, but also other mesenchymal tissues, such adipose tissue and dermis, have been considered (2).
Recently, Amniotic Epithelial Cells (AECs) have been extensively studied as another interesting source of SCs, for the high proliferative potential in culture, multipotent differentiation ability and easy availability (3). A low immunogenicity have been also suggested by their survival, in some allograft and xenograft studies (4–6). However, the survival has never been studied in tendons xenograft.
Aim of this report is twofold: first, to investigate whether ovine AECs (oAECs) have low immunogenicity, when implanted into spontaneous tendinopathy of the superficial digital flexor tendon (SDFT) in the horse; second, to evaluate whether these cells can enhance the functional recovery following a rehabilitation program. Two racehorses, suffering from monolateral SDFT tendinopathy of the thoracic limb (clinical and ultrasound diagnosis), were studied. Cells were obtained from the epithelial layer of the amniotic membrane of sheep (4) and, before injection, were stained with a vital membrane fluorescent probe to identify the transferred cells into the host tissue. A real time ultrasound (US) guided injection of the affected area inside the tendon was performed, and a total of 7 × 106 oAECs was grafted into the lesion.
After implantation, horses were rested in box for 7 days before starting a rehabilitation program (walking in hand on hard surface, for 15 min, twice a day, until day 40). US controls were performed after 15, 30 and 40 days.
At 40 days, a real – time US guided biopsy of treated area was performed, and the specimens obtained were analyzed for: 1) hematoxylin – eosin (HE) and Herovici histological stainings; 2) nuclear contrast with fluorescent DAPI staining; 3) immunoreactions (IHC) with a cellular proliferation marker Ki67. Histological analyses demonstrated, inside the treated lesion, the presence of cells with the vital probe on their membrane, and newly ovine deposited collagen! fibres (HE staining). No evidence of mononuclear cells population was observed. At US control, after 15 and 30 days, the affected region appeared widened and the hypoechoic areas were still present; at 40 days, in both cases, US imaging demonstrated a more homogeneous pattern of the treated areas, which were reduced in extent and less hypoechoic. Clinical conditions of both horses improved, but they were withdrawn from racing.
This study suggests that transplanted oAECs survive inside tendinopathic areas. Indeed, marked cells are still detectable 40 days after transplantation. Their very low immunogenetic potential could be probably related to the expression of HLA – G, which displays inhibitory functions relevant to immune responses (7, 8).
In addition, on the basis of US and histological results, it can be hypothesized that implanted cells may transdifferentiate into mesenchymal cells and have an healing potential. Indeed, newly ovine formed collagen fibers are seen near the cells, while tendon echotexture acquires a more normal appearance. These results can be also related to the beneficial effects of the rehabilitation program. The mechanical loading, together with the stretching of the tendon, promotes the synthesis of collagen and improves reorganization.
References
- 1.Obaid H, Connell D. Cell therapy in tendon disorders: what is the current evidence? Am J Sports Med. 2010;38:2123–2132. doi: 10.1177/0363546510373574. [DOI] [PubMed] [Google Scholar]
- 2.Yang M, Li Q, Sheng L, Li H, Weng R, Zan T. Bone marrow-derived mesenchymal stem cells transplantation accelerates tissue expansion by promoting skin regeneration during expansion. Ann Surg. 2011;253:202–209. doi: 10.1097/SLA.0b013e3181f9ba1ah. [DOI] [PubMed] [Google Scholar]
- 3.Niknejad H, Peirovi H, Jorjani M, Ahmadiani A, Ghanavi J, Seifalian AM. Properties of the amniotic membrane for potential use in tissue engineering. Eur Cell Mater. 2008;29:88–99. doi: 10.22203/ecm.v015a07. [DOI] [PubMed] [Google Scholar]
- 4.Muttini A, Mattioli M, Petrizzi L, Varasano V, Sciarrini C, Russo V, Mauro A, Cocciolone D, Turriani M, Barboni B. Experimental study on allografts of amniotic epithelial cells in calcaneal tendon lesions of sheep. Vet Res Commun. 2010;34:S117–120. doi: 10.1007/s11259-010-9396-z. [DOI] [PubMed] [Google Scholar]
- 5.Bailo M, Soncini M, Vertua E, Signoroni PB, Sanzone S, Lombardi G, Arienti D, Calamani F, Zatti D, Paul P, Albertini A, Zorzi F, Cavagnini A, Candotti F, Wengler GS, Parolini O. Engraftment potential of human amnion and chorion cells derived from term placenta. Transplantation. 2004;78:1439–1448. doi: 10.1097/01.tp.0000144606.84234.49. [DOI] [PubMed] [Google Scholar]
- 6.Cargnoni A, Gibelli L, Tosini A, Signoroni PB, Nassuato C, Arienti D, Lombardi G, Albertini A, Wengler GS, Parolini O. Transplantation of allogeneic and xenogeneic placenta–derived cells reduces bleomycin–induced lung fibrosis. Cell Transplant. 2009;18:405–422. doi: 10.3727/096368909788809857. [DOI] [PubMed] [Google Scholar]
- 7.Hori J, Wang M, Kamiya K, Takahashi H, Sakuragawa N. Immunological characteristics of amniotic epithelium. Cornea. 2006;25:S53–58. doi: 10.1097/01.ico.0000247214.31757.5c. [DOI] [PubMed] [Google Scholar]
- 8.Hunt JS, Petroff MG, McIntire RH, Ober C. HLA–G and immune tolerance in pregnancy. FASEB J. 2005;19:68–93. doi: 10.1096/fj.04-2078rev. [DOI] [PubMed] [Google Scholar]
